DAWN: dayonebio.com Amount of Cash per Share

Corporate emblem and logo of Day One (DAWN)

Cash per share for Day One (DAWN) demonstrates current liquidity, where the value of 4.30 characterizes this level. The trend is supported by the implementation of eco-friendly emission filtration systems and dominance in pediatric oncology without engaging in price wars. The final trend confirms the business's macro-stability, as demand for pediatric therapy is not subject to seasonal fluctuations or cycles.

DAWN: Day One Biopharmaceuticals, Inc. Cash per Share 07/04/2022 - 05/09/2026

Analytical breakdowns for Day One

- market price and analyst price targets:
- cash position and cash flow details:
Summary company analysis:DAWN, Day One Biopharmaceuticals Inc
Original product of dayonebio.com

This calculated indicator determines the volume of liquid reserves per common share, allowing for an assessment of the financial cushion available for business expansion. The trend of highly liquid assets per share reflects the rate of capital expenditure on the commercialization of Ojemda and the development of the oncology pipeline, serving as a key marker of Day One (DAWN) operational resilience ahead of a potential acquisition.